Carolina Amputee Care Inc is categorized under Artificial Limb Manufacturers in Conover, NC and active since 1994.
Carolina Amputee Care Inc was established in 1994, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Artificial Limb Manufacturers business, which does work in the B2B market, and is classified as a Artificial Limb Manufacturers, under code number 339113 by the NAICS.
If you are seeking more information, feel free to contact John L Rufty Jr at the company’s single location by writing to 502 1st Avenue South, Conover, North Carolina NC 28613 or by phoning (828) 464-2011. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Carolina Amputee Care Inc |
| Contact Person: | John L Rufty Jr |
| Address: | 502 1st Avenue South, Conover, North Carolina 28613 |
| Phone Number: | (828) 464-2011 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Artificial Limb Manufacturers |
| SIC Code: | 3842 |
| NAICS Code: | 339113 |
| Share This Business: |
Carolina Amputee Care Inc was started in 1994 to provide professional Artificial Limb Manufacturers under the SIC code 3842 and NAICS code 339113. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact John L Rufty Jr for inquiries that concern Carolina Amputee Care Inc by calling the company number (828) 464-2011, as your correspondence is most welcome. Additionally, the physical location of the single location of Carolina Amputee Care Inc can be found at the coordinates as well as the street address 502 1st Avenue South in Conover, North Carolina 28613.
For its online presence, you may visit Carolina Amputee Care Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.